Loading…
Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells
Glioblastoma multiforme (GBM) continues to be associated with a dismal prognosis despite aggressive treatment. Significant efforts are being made to develop new nanotechnology-based therapeutic and diagnostic agents. Nanoparticles can act directly on cancer cells or as drug carriers to enhance the c...
Saved in:
| Published in: | Oncotarget 2017-01, Vol.8 (5), p.7533-7539 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c356t-14695624e5470b9719be539af40b9f759eefb086e0dc7e51ac2603c4d17536e33 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c356t-14695624e5470b9719be539af40b9f759eefb086e0dc7e51ac2603c4d17536e33 |
| container_end_page | 7539 |
| container_issue | 5 |
| container_start_page | 7533 |
| container_title | Oncotarget |
| container_volume | 8 |
| creator | Liang, Ping Shi, Hongming Zhu, Weiguo Gui, Qunfeng Xu, Ya Meng, Jianfeng Guo, Xiaoyuan Gong, Zhuang Chen, Huaqun |
| description | Glioblastoma multiforme (GBM) continues to be associated with a dismal prognosis despite aggressive treatment. Significant efforts are being made to develop new nanotechnology-based therapeutic and diagnostic agents. Nanoparticles can act directly on cancer cells or as drug carriers to enhance the cancer therapeutic effect. In this study, we investigated the effect of silver nanoparticles (AgNPs) on human glioma U251 cells and its role in the combinational use with Temozolomide (TMZ), an imidazotetrazine derivative of the alkylating agent dacarbazine, against glioma cells. AgNPs were synthesized in the sodium citrate system and the mean size were 26 nm in diameter. The AgNP particles showed dose-dependent cytotoxicity on U251 cells. They also showed the ability to enhance the drug-sensitivity of TMZ on U251 cells. Our results revealed that AgNPs could have a potential application in enhancing chemotherapy for glioma. |
| doi_str_mv | 10.18632/oncotarget.13503 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5352340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1844609648</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-14695624e5470b9719be539af40b9f759eefb086e0dc7e51ac2603c4d17536e33</originalsourceid><addsrcrecordid>eNpVUUtLAzEQDqJY0f4AL5Kjl9Zk89jNRZDiCwqCj3NI09k2spvUJC3or3dta61zmRlm5ptv5kPonJIhrSQrroK3IZs4gzykTBB2gE6o4mpQCMEO9-Ie6qf0TjoTvKwKdYx6RVkpxqk6Qc8vrllBxN74sDAxO9tAwuDnxlvAeQ44gU8uu5XLnzjUOEMbvkITWjcFHDyeL1vj8axxoTXYQtOkM3RUmyZBf-tP0dvd7evoYTB-un8c3YwHlgmZB5RLJWTBoWNFJqqkagKCKVPzLqtLoQDqCakkkKktQVBjC0mY5VNaCiaBsVN0vcFdLCctTC34HE2jF9G1Jn7qYJz-X_FurmdhpQUTBeOkA7jcAsTwsYSUdevSzwnGQ1gmTSvOJVGSV10r3bTaGFKKUO_WUKLXcug_OfRajm7mYp_fbuL3-ewbxvuK6Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1844609648</pqid></control><display><type>article</type><title>Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells</title><source>PubMed Central</source><creator>Liang, Ping ; Shi, Hongming ; Zhu, Weiguo ; Gui, Qunfeng ; Xu, Ya ; Meng, Jianfeng ; Guo, Xiaoyuan ; Gong, Zhuang ; Chen, Huaqun</creator><creatorcontrib>Liang, Ping ; Shi, Hongming ; Zhu, Weiguo ; Gui, Qunfeng ; Xu, Ya ; Meng, Jianfeng ; Guo, Xiaoyuan ; Gong, Zhuang ; Chen, Huaqun</creatorcontrib><description>Glioblastoma multiforme (GBM) continues to be associated with a dismal prognosis despite aggressive treatment. Significant efforts are being made to develop new nanotechnology-based therapeutic and diagnostic agents. Nanoparticles can act directly on cancer cells or as drug carriers to enhance the cancer therapeutic effect. In this study, we investigated the effect of silver nanoparticles (AgNPs) on human glioma U251 cells and its role in the combinational use with Temozolomide (TMZ), an imidazotetrazine derivative of the alkylating agent dacarbazine, against glioma cells. AgNPs were synthesized in the sodium citrate system and the mean size were 26 nm in diameter. The AgNP particles showed dose-dependent cytotoxicity on U251 cells. They also showed the ability to enhance the drug-sensitivity of TMZ on U251 cells. Our results revealed that AgNPs could have a potential application in enhancing chemotherapy for glioma.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.13503</identifier><identifier>PMID: 27893419</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Antineoplastic Agents, Alkylating - pharmacology ; Antineoplastic Combined Chemotherapy Protocols - pharmacology ; Apoptosis - drug effects ; Brain Neoplasms - drug therapy ; Brain Neoplasms - pathology ; Cell Line, Tumor ; Cell Proliferation - drug effects ; Dacarbazine - analogs & derivatives ; Dacarbazine - pharmacology ; Dose-Response Relationship, Drug ; G2 Phase Cell Cycle Checkpoints - drug effects ; Glioma - drug therapy ; Glioma - pathology ; Humans ; Metal Nanoparticles ; Research Paper ; Silver Compounds - pharmacology</subject><ispartof>Oncotarget, 2017-01, Vol.8 (5), p.7533-7539</ispartof><rights>Copyright: © 2017 Liang et al. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-14695624e5470b9719be539af40b9f759eefb086e0dc7e51ac2603c4d17536e33</citedby><cites>FETCH-LOGICAL-c356t-14695624e5470b9719be539af40b9f759eefb086e0dc7e51ac2603c4d17536e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352340/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352340/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27893419$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liang, Ping</creatorcontrib><creatorcontrib>Shi, Hongming</creatorcontrib><creatorcontrib>Zhu, Weiguo</creatorcontrib><creatorcontrib>Gui, Qunfeng</creatorcontrib><creatorcontrib>Xu, Ya</creatorcontrib><creatorcontrib>Meng, Jianfeng</creatorcontrib><creatorcontrib>Guo, Xiaoyuan</creatorcontrib><creatorcontrib>Gong, Zhuang</creatorcontrib><creatorcontrib>Chen, Huaqun</creatorcontrib><title>Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>Glioblastoma multiforme (GBM) continues to be associated with a dismal prognosis despite aggressive treatment. Significant efforts are being made to develop new nanotechnology-based therapeutic and diagnostic agents. Nanoparticles can act directly on cancer cells or as drug carriers to enhance the cancer therapeutic effect. In this study, we investigated the effect of silver nanoparticles (AgNPs) on human glioma U251 cells and its role in the combinational use with Temozolomide (TMZ), an imidazotetrazine derivative of the alkylating agent dacarbazine, against glioma cells. AgNPs were synthesized in the sodium citrate system and the mean size were 26 nm in diameter. The AgNP particles showed dose-dependent cytotoxicity on U251 cells. They also showed the ability to enhance the drug-sensitivity of TMZ on U251 cells. Our results revealed that AgNPs could have a potential application in enhancing chemotherapy for glioma.</description><subject>Antineoplastic Agents, Alkylating - pharmacology</subject><subject>Antineoplastic Combined Chemotherapy Protocols - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>Brain Neoplasms - drug therapy</subject><subject>Brain Neoplasms - pathology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation - drug effects</subject><subject>Dacarbazine - analogs & derivatives</subject><subject>Dacarbazine - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>G2 Phase Cell Cycle Checkpoints - drug effects</subject><subject>Glioma - drug therapy</subject><subject>Glioma - pathology</subject><subject>Humans</subject><subject>Metal Nanoparticles</subject><subject>Research Paper</subject><subject>Silver Compounds - pharmacology</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVUUtLAzEQDqJY0f4AL5Kjl9Zk89jNRZDiCwqCj3NI09k2spvUJC3or3dta61zmRlm5ptv5kPonJIhrSQrroK3IZs4gzykTBB2gE6o4mpQCMEO9-Ie6qf0TjoTvKwKdYx6RVkpxqk6Qc8vrllBxN74sDAxO9tAwuDnxlvAeQ44gU8uu5XLnzjUOEMbvkITWjcFHDyeL1vj8axxoTXYQtOkM3RUmyZBf-tP0dvd7evoYTB-un8c3YwHlgmZB5RLJWTBoWNFJqqkagKCKVPzLqtLoQDqCakkkKktQVBjC0mY5VNaCiaBsVN0vcFdLCctTC34HE2jF9G1Jn7qYJz-X_FurmdhpQUTBeOkA7jcAsTwsYSUdevSzwnGQ1gmTSvOJVGSV10r3bTaGFKKUO_WUKLXcug_OfRajm7mYp_fbuL3-ewbxvuK6Q</recordid><startdate>20170131</startdate><enddate>20170131</enddate><creator>Liang, Ping</creator><creator>Shi, Hongming</creator><creator>Zhu, Weiguo</creator><creator>Gui, Qunfeng</creator><creator>Xu, Ya</creator><creator>Meng, Jianfeng</creator><creator>Guo, Xiaoyuan</creator><creator>Gong, Zhuang</creator><creator>Chen, Huaqun</creator><general>Impact Journals LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170131</creationdate><title>Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells</title><author>Liang, Ping ; Shi, Hongming ; Zhu, Weiguo ; Gui, Qunfeng ; Xu, Ya ; Meng, Jianfeng ; Guo, Xiaoyuan ; Gong, Zhuang ; Chen, Huaqun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-14695624e5470b9719be539af40b9f759eefb086e0dc7e51ac2603c4d17536e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antineoplastic Agents, Alkylating - pharmacology</topic><topic>Antineoplastic Combined Chemotherapy Protocols - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>Brain Neoplasms - drug therapy</topic><topic>Brain Neoplasms - pathology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation - drug effects</topic><topic>Dacarbazine - analogs & derivatives</topic><topic>Dacarbazine - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>G2 Phase Cell Cycle Checkpoints - drug effects</topic><topic>Glioma - drug therapy</topic><topic>Glioma - pathology</topic><topic>Humans</topic><topic>Metal Nanoparticles</topic><topic>Research Paper</topic><topic>Silver Compounds - pharmacology</topic><toplevel>online_resources</toplevel><creatorcontrib>Liang, Ping</creatorcontrib><creatorcontrib>Shi, Hongming</creatorcontrib><creatorcontrib>Zhu, Weiguo</creatorcontrib><creatorcontrib>Gui, Qunfeng</creatorcontrib><creatorcontrib>Xu, Ya</creatorcontrib><creatorcontrib>Meng, Jianfeng</creatorcontrib><creatorcontrib>Guo, Xiaoyuan</creatorcontrib><creatorcontrib>Gong, Zhuang</creatorcontrib><creatorcontrib>Chen, Huaqun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liang, Ping</au><au>Shi, Hongming</au><au>Zhu, Weiguo</au><au>Gui, Qunfeng</au><au>Xu, Ya</au><au>Meng, Jianfeng</au><au>Guo, Xiaoyuan</au><au>Gong, Zhuang</au><au>Chen, Huaqun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2017-01-31</date><risdate>2017</risdate><volume>8</volume><issue>5</issue><spage>7533</spage><epage>7539</epage><pages>7533-7539</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Glioblastoma multiforme (GBM) continues to be associated with a dismal prognosis despite aggressive treatment. Significant efforts are being made to develop new nanotechnology-based therapeutic and diagnostic agents. Nanoparticles can act directly on cancer cells or as drug carriers to enhance the cancer therapeutic effect. In this study, we investigated the effect of silver nanoparticles (AgNPs) on human glioma U251 cells and its role in the combinational use with Temozolomide (TMZ), an imidazotetrazine derivative of the alkylating agent dacarbazine, against glioma cells. AgNPs were synthesized in the sodium citrate system and the mean size were 26 nm in diameter. The AgNP particles showed dose-dependent cytotoxicity on U251 cells. They also showed the ability to enhance the drug-sensitivity of TMZ on U251 cells. Our results revealed that AgNPs could have a potential application in enhancing chemotherapy for glioma.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>27893419</pmid><doi>10.18632/oncotarget.13503</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1949-2553 |
| ispartof | Oncotarget, 2017-01, Vol.8 (5), p.7533-7539 |
| issn | 1949-2553 1949-2553 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5352340 |
| source | PubMed Central |
| subjects | Antineoplastic Agents, Alkylating - pharmacology Antineoplastic Combined Chemotherapy Protocols - pharmacology Apoptosis - drug effects Brain Neoplasms - drug therapy Brain Neoplasms - pathology Cell Line, Tumor Cell Proliferation - drug effects Dacarbazine - analogs & derivatives Dacarbazine - pharmacology Dose-Response Relationship, Drug G2 Phase Cell Cycle Checkpoints - drug effects Glioma - drug therapy Glioma - pathology Humans Metal Nanoparticles Research Paper Silver Compounds - pharmacology |
| title | Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T02%3A19%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Silver%20nanoparticles%20enhance%20the%20sensitivity%20of%20temozolomide%20on%20human%20glioma%20cells&rft.jtitle=Oncotarget&rft.au=Liang,%20Ping&rft.date=2017-01-31&rft.volume=8&rft.issue=5&rft.spage=7533&rft.epage=7539&rft.pages=7533-7539&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.13503&rft_dat=%3Cproquest_pubme%3E1844609648%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-14695624e5470b9719be539af40b9f759eefb086e0dc7e51ac2603c4d17536e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1844609648&rft_id=info:pmid/27893419&rfr_iscdi=true |